VTYX•globenewswire•
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London
Summary
SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, today announced that Company executives will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference in London.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 17, 2025 by globenewswire